Log In
Print this Print this

Oxytrol, oxybutynin (Oxytrol patch)

  Manage Alerts
Collapse Summary General Information
Company Allergan plc
DescriptionTransdermal tertiary amine anticholinergic agent
Molecular Target Muscarinic receptor
Mechanism of ActionMuscarinic receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationIncontinence
Indication DetailsTreat incontinence; Treat overactive bladder (OAB)
Regulatory Designation
PartnerEndo International plc;
Merck & Co. Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today